Advancing Cancer Diagnostics
Improving Lives
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

2016 Revision of WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, Non-Hematopathologist, (Part 2 of 2)


Review the most important changes to the WHO hematopathology classification system as part of the 2016 revision. Emphasis will be placed on presenting the information so that it is relevant and understandable by non-hematopathologists and laboratory staff. This will be a two-part presentation, with the first lecture covering lymphoid neoplasms and the second presentation covering myeloid and precursor neoplasms. September 15, 2016 was part one of the series.

Learning Objectives:

  1. Understand the need for the 2016 revision to the 2008 WHO hematopathology classification system.
  2. Review pertinent changes involving lymphoid neoplasms in a manner understandable by general pathologists and laboratory staff.
  3. Illustrate important situations where advanced testing (e.g. IHC, molecular, FISH) may be helpful in further distinguishing hematopoietic neoplasms, which had been difficult to classify or confirm with certainty in the past.